Muscle Function and Relaxation
Magnesium supports muscle contraction and relaxation by regulating calcium levels and acting as a cofactor for enzymes involved in muscle energy production, reducing cramps and spasms.
Bone Health
Magnesium contributes to bone strength by aiding calcium absorption and activating vitamin D, supporting bone mineralization and reducing osteoporosis risk.
Heart Health
Magnesium promotes cardiovascular health by regulating heart rhythm, supporting blood vessel relaxation, and lowering blood pressure through its role in ion channel function.
Nervous System Support
Magnesium calms the nervous system by modulating NMDA receptors and GABA activity, reducing stress, anxiety, and promoting better sleep quality.
Energy Production
Magnesium is a cofactor for over 300 enzymatic reactions, including those in ATP synthesis, supporting cellular energy production and reducing fatigue.
Blood Sugar Regulation
Magnesium improves insulin sensitivity and glucose metabolism by enhancing insulin receptor function, potentially lowering the risk of type 2 diabetes.
Migraine Prevention
Magnesium may reduce the frequency and severity of migraines by stabilizing neuronal activity and reducing cortical spreading depression, a mechanism linked to migraines.
Muscle Function and Relaxation
Magnesium regulates muscle contraction and relaxation by acting as a natural calcium channel blocker, binding to and modulating calcium ion channels to prevent excessive muscle contraction, while also serving as a cofactor for enzymes like creatine kinase in ATP-dependent muscle energy metabolism.
Bone Health
Magnesium supports bone health by facilitating calcium absorption through its role in parathyroid hormone regulation and activating 25-hydroxyvitamin D to its active form, 1,25-dihydroxyvitamin D, which enhances osteoblast activity and bone mineralization.
Heart Health
Magnesium maintains heart rhythm and vascular tone by modulating sodium-potassium ATPase and calcium channels, stabilizing cardiac cell membranes, and promoting vasodilation through nitric oxide synthase activation, which lowers blood pressure.
Nervous System Support
Magnesium calms the nervous system by inhibiting excitatory NMDA receptor activity and enhancing inhibitory GABA receptor function, reducing neuronal excitability and promoting relaxation, which aids in stress reduction and sleep.
Energy Production
Magnesium acts as a cofactor for enzymes in glycolysis and the Krebs cycle, including hexokinase and phosphofructokinase, stabilizing ATP and facilitating its transfer in energy-producing reactions, thus supporting cellular energy metabolism.
Blood Sugar Regulation
Magnesium enhances insulin sensitivity by promoting tyrosine kinase activity on insulin receptors and supporting glucose transporter (GLUT4) translocation to cell membranes, improving glucose uptake and metabolism.
Migraine Prevention
Magnesium reduces migraine frequency by inhibiting cortical spreading depression through NMDA receptor modulation and stabilizing neuronal membranes, while also reducing vasoconstriction by inhibiting calcium-mediated neurotransmitter release.
Study: A double-blind, randomized clinical trial (September 2021–March 2022) at Razi Hospital, Iran, investigated magnesium supplementation (300 mg daily) in 64 patients with moderate COVID-19.
Findings: Reduced need fo
r oxygen therapy (9 vs. 14 patients, P<0.001), improved oxygen saturation (4.55 ± 2.35 vs. 1.8 ± 1.67, P<0.001), and enhanced quality of life and depression scores. No significant changes in respiratory rate, fever, or inflammatory markers like hs-CRP and TNF-α.
Magnesium for Cancer Treatment-Induced Hypomagnesemia
Study: A pilot randomized trial (2016–2017) compared magnesium oxide (MgOx) and magnesium citrate (MgCit) in 15 patients receiving platinum-based chemotherapy or EGFR inhibitors.
Findings: Achieved 100% patient engagement but low accrual rate (1 patient/month). No significant differences in magnesium levels, cardiac arrhythmias, or treatment delays, suggesting further studies are needed.
Magnesium for Depression
Study: A 2017 open-label, randomized crossover trial in 126 adults with mild-to-moderate depression tested magnesium chloride (248 mg elemental magnesium daily).
Findings: After 6 weeks, significantly reduced depression scores (PHQ-9: -6.0 points, P<0.001) and anxiety scores (GAD-7: -4.5 points, P<0.001), with effects seen within weeks but diminishing after discontinuation.
Magnesium for Sleep and Mood
Study: A double-blind trial by Upgraded Formulas (2024) tested a magnesium supplement.
Findings: Improved REM sleep by 160% and deep sleep by 250% compared to placebo, alongside better mood and sleep balance scores.
Magnesium for Bone Health
Study: A 12-month double-blind trial in children and adolescents with low magnesium intake (300 mg magnesium oxide daily) and another in postmenopausal women with osteoporosis (250–750 mg magnesium hydroxide daily for 2 years).
Findings: Increased bone mineral content in children and improved bone density in women.
Magnesium for Blood Pressure
Study: A meta-analysis of 20 randomized trials (1220 participants) examined magnesium supplementation (10–40 mmol/day).
Findings: Small reductions in systolic (-0.6 mm Hg) and diastolic (-0.8 mm Hg) blood pressure, with dose-dependent effects suggested but requiring further confirmation.
Magnesium for Cerebral Infarcts
Study: Small clinical trials (over 100 patients) tested magnesium sulfate infusions for stroke, with a larger multicenter trial ongoing.
Findings: Showed neuroprotective trends without adverse effects; larger trial results pending.
Magnesium for Cognitive Function
Study: A 2017 open-label trial of magnesium L-threonate in 15 patients with mild-to-moderate dementia and another in adults aged 50–70.
Findings: Improved cerebral metabolism and cognitive function after 12 weeks in dementia patients; cognitive improvements in older adults, reversing brain aging by ~9 years. Larger placebo-controlled trials needed.
Magnesium status and supplementation influence vitamin D status and metabolism: results from a randomized trial
Study: Investigate whether magnesium supplementation, specifically magnesium glycinate, optimizes vitamin D status by improving serum 25-hydroxyvitamin D (25(OH)D) levels, which is critical for calcium absorption and bone health. Participants underwent baseline assessments of magnesium and vitamin D status, followed by randomization to magnesium supplementation or placebo, with follow-up measurements to assess changes in 25(OH)D levels.
Findings: In participants with baseline 25(OH)D levels ≥30 ng/mL (vitamin D sufficient), magnesium supplementation increased 25(OH)D levels by an average of 3–5 ng/mL compared to placebo (p<0.05). In those with baseline 25(OH)D levels <30 ng/mL (vitamin D insufficient), magnesium supplementation either maintained or slightly decreased 25(OH)D levels, suggesting a complex interaction depending on baseline status. Magnesium supplementation increased 1,25(OH)2D levels in participants with low baseline vitamin D status, indicating enhanced conversion of 25(OH)D to its active form.